interlakenobfuscate@smu.edu.cn
Dongqiang Zeng
Lab Co-Director

Academic Appointments & Leadership

Editorial Roles

  • Youth Editorial Board Member, iMeta (Q1 journal in bioinformatics)
  • Youth Editorial Board Member, MedCom-Future Medicine

Key Committee Positions

  • Standing Committee Member, Oncology Branch of Guangzhou Medical Association
  • Committee Member, Tumor Immunotherapy Committee of Guangdong Pharmaceutical Association
  • Committee Member, Gastrointestinal Oncology Group of Guangdong Medical Association

Research Focus

Dr. Zeng pioneers translational research in tumor microenvironment (TME) and mRNA cancer vaccines. His lab leverages multi-omics approaches to:

  • Decipher immunosuppressive networks: Analyze TME-driven immunosuppressive mechanisms to advance precision immunotherapy
  • Engineer next-generation vaccines: Design mRNA vaccines targeting neoantigens and stromal barriers
  • Develop AI-integrated tools:
    • Create spatial TME deconvolution algorithms
    • Discover clinical biomarkers

Notable Achievements

Awards

  • 2023 Chinese Medical Science and Technology Award (Third Prize)
  • 2021 AACR Best Research Award (American Association for Cancer Research)
  • 2019 AACR-KCA Young Investigator Award

Research
Papers